Browsing Category

Top Industry News

7283 posts

Lilly Announces Plans to Build Four New Mfg Sites in US 
By

By
Eli Lilly and Company has announced plans to bolster its domestic medicine production by building four new pharmaceutical manufacturing sites in the US. This new investment brings the company’s total…

Thermo Fisher To Acquire Solventum’s Purification & Filtration Business for $4.1 Bn 
By

By
Thermo Fisher Scientific has agreed to acquire the purification and filtration business of Solventum, a Saint Paul, Minnesota-based healthcare company, for $4.1 billion.  Solventum, which was spun off from 3M…

GSK Completes $1.15-Bn Acquisition of IDRx 
By

By
GSK has completed its acquisition of IDRx, a Boston-based, clinical-stage bio/pharmaceutical company, in a deal worth up to $1.1 billion ($1 billion upfront and $150 million in milestone payments). The…

Investment Firms To Acquire Gene Therapy Company bluebird bio  
By

By
bluebird bio, a Somerville, Massachusetts-based company specializing in gene therapies, has agreed to be acquired by funds managed by the global investment firms, Carlyle and SK Capital Partners.   David Meek,…

Cosette Pharmaceuticals To Acquire Mayne Pharma for $430 M 
By

By
Cosette Pharmaceuticals, a Bridgewater, New Jersey-based bio/pharmaceutical company, has agreed to acquire Mayne Pharma Group, a Raleigh, North Carolina-based bio/pharmaceutical company, for $430 Million.   The acquisition would strengthen Cosette’s product…

Supplier News: Granules & Sai Life Sciences
By

By
The latest from CDMOs, CMOs, and suppliers featuring Granules, Senn Chemicals and Sai Life Sciences.   Chemicals/Chemical API Manufacturing * Granules To Acquire Swiss Peptide CDMO Senn Chemicals * Sai Life Sciences Completes…

Sanofi To Sell 50% Stake of its Consumer Healthcare Business Opella to CD&R 
By

By
Sanofi has agreed to sell a 50% controlling stake in its consumer healthcare business, Opella, to CD&R, an investment firm.  Sanofi had first announced that it was in negotiations to…

AbbVie Names CEO as New Chairman 
By

By
The Board of Directors at AbbVie has unanimously elected Robert Michael, the company’s current CEO, to assume the additional position of Chairman, effective July 1, 2025. He will succeed Richard…

FDA Oks Sanofi’s Insulin Biosimilar to Novo Nordisk’s NovoLog 
By

By
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novo Nordisk’s NovoLog (insulin aspart), called NovoRapid outside of the US, for the improvement of…

Supplier News: Seqens, Alcami & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Seqens, Alcami, and Asahi Kasei Bioprocess America.   Chemicals/Chemical API Manufacturing * Seqens Names New CEO Biologics Manufacturing * Asahi Kasei Bioprocess America Names New President Formulation…